IBA and SOGAZ Insurance Group sign contract for Proteus®ONE proton therapy solution in Russia
14 Février 2022 - 07:00AM
IBA and SOGAZ Insurance Group sign contract for Proteus®ONE proton
therapy solution in Russia
Louvain-La-Neuve, Belgium, February 14,
2022 – IBA (Ion Beam Applications S.A., EURONEXT), the
world leader in particle accelerator technology and the world’s
leading provider of proton therapy solutions for the treatment of
cancer, today announces a new contract with SOGAZ Insurance Group
(“SOGAZ Group”) for the installation of a
Proteus®ONE1 proton therapy solution in Saint
Petersburg, Russia. The contract includes a multi-year operation
and maintenance agreement to be provided by IBA. SOGAZ Group
expects to start treating patients in 2024.
The system is the first Proteus®ONE solution to
be installed in Russia, located at the SOGAZ High-tech
Multidisciplinary Medical Complex, in Jukki, just outside of Saint
Petersburg. It will be equipped with latest generation Open Gantry,
Pencil Beam Scanning (PBS), Cone Beam Computed Tomography (CBCT),
wireless hand pendant and a fully integrated quality assurance (QA)
hardware and software package from IBA Dosimetry GmbH. Notably, the
Proteus®ONE system previously demonstrated its ability to deliver
Flash Ultra High Dose Rates at Isocenter in a clinical environment2
The Proteus®ONE is the latest generation cyclotron-based compact
proton therapy system with market clearance in the Russian
Federation today.
The typical end-user price for a Proteus®ONE
system with a multi-year maintenance contract ranges between 35-45
million EUR. IBA has received the first payment and will start
recognizing this revenue in 2022. This is the 31st Proteus®ONE
system sold worldwide, of which, 12 are currently clinically
operational.
Olivier Legrain, Chief Executive Officer
of IBA, commented: “This latest contract further
demonstrates the growing momentum of proton therapy worldwide,
whilst reinforcing IBA’s leading position in the Russian market. We
look forward to partnering with SOGAZ and are pleased to welcome
them to IBA Campus3, the largest community of proton therapy
experts.”
Anton Ustinov, Chairman
of the Management Board of SOGAZ Group, added, “SOGAZ
Group seeks to provide the latest and most advanced medical
technology to our cancer patients in need of the best possible
care. Adding proton therapy to our clinic will provide additional
treatment options for our world-class clinicians. We are glad to
partner with IBA which continues to be the leader in proton therapy
innovation.
***Ends***
About IBA
IBA (Ion Beam Applications S.A.) is the world
leader in particle accelerator technology. The company is the
leading supplier of equipment and services in the field of proton
therapy, considered to be the most advanced form of radiation
therapy available today. IBA is also a leading player in the fields
of industrial sterilization, radiopharmaceuticals and dosimetry.
The company, based in Louvain-la-Neuve, Belgium, employs
approximately 1,500 people worldwide. IBA is a certified B
Corporation (B Corp) meeting the highest standards of verified
social and environmental performance.
IBA is listed on the pan-European stock exchange
EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at:
www.iba-worldwide.com
About Sogaz Insurance GroupSOGAZ Insurance
Group was founded in 1993 and is the largest federal level insurer
in Russia. The group offers more than 100 insurance programs for
individuals and enterprises in various fields of activity.
Reliability and financial stability of the Group companies are
proved by leading international and Russian rating agencies. The
regional network of the Group includes more than 1,000 divisions
and sales offices throughout Russia.
CONTACTS
Soumya
ChandramouliChief Financial Officer+32 10
475 890Investorrelations@iba-group.com
Olivier LechienCorporate
Communication Director+32 10 475 890communication@iba-group.com
Consilium Strategic
CommunicationsAmber Fennell, Angela Gray, Lucy
Featherstone+44 (0) 20 3709 5700IBA@consilium-comms.com
1 Proteus®ONE is a brand name of Proteus 235
2
https://www.iba-worldwide.com/content/flash-irradiation-delivered-proteus-one-treatment-room
3 Connect on Campus-iba.com to join the largest community of
proton therapy experts .
- 220214-P1-SOGAZ-Russia-EN
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Ion Beam Applications (EU:IBAB)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024